Congress
STAT covers Congress with a focus on healthcare, drug pricing and other important issues of public health. Read our in-depth reporting and analysis to stay informed about what’s happening in Washington, D.C. and how it affects your health and your community.
Latest
STAT Plus: BIO severs ties with WuXi in the face of U.S. government concerns over China
STAT Plus: Geron’s resurgence might have been short-lived
STAT Plus: Good health care price transparency rules are at risk if Congress doesn’t act
STAT Plus: Biden calls for election wake-up call on abortion rights — but new upheavals are fast approaching
STAT Plus: In his State of the Union, Biden takes clear aim at ‘Big Pharma’
STAT Plus: Banning WuXi is more complicated than it might sound
STAT Plus: Senate panel advances bill to ban some Chinese biotechs, with Sen. Paul taking up industry’s cause
All Coverage
advertisement
